UMASTAR - The Best technology for dry eye relief - Preservative Free Ophthalmic Solution

UMASTAR - The Best technology for dry eye relief - Preservative Free Ophthalmic Solution
Product Description

A tear substitute used for the protection, hydration and lubrication of the eye surface.
Indications.
Umastar Ophthalmic Solution is a preservative-free tearsubstitute. It contains cross-linked hyaluronic acid sodiumsalt and carboxymethyl β-glucan. Umastar Ophthalmic Solution is used for the protection,hydration and lubrication of the eye surface. The cross-linked hyaluronic acid sodium salt, due to itsreticular structure, guarantees a greater hydration andviscoelasticity, a high stability of the tear film and remainsfor a long time on the ocular surface. The carboxymethyl β-glucan, in addition to increasingthe lubricating ability of the product, counteracts theoxidative stress caused by free radicals and supports thereorganization of the corneal cells. The OSD (Ophthalmic Squeeze Dispenser) technologyallows the innovative delivery of an absolutely sterilepreservative-free ophthalmic solution. Umastar Ophthalmic Solution is indicated for thetreatment of the symptomatology (dryness, foreign bodysensation, etc.) associated with

  • Dry eye
  • Mechanical stress: use of contact lenses, surgicalprocedures, etc.
  • Systemic diseases: Sjögren‘s syndrome, rheumatoidarthritis, liver disease, etc.
  • Hormonal disorders: menopause, hormone replacementtherapy, etc.
  • Environmental stress: air conditioning, cigarette smoke,wind, etc.
  • Visual stress: use of video terminal.
  • Use of drugs: antidepressants, beta-blockers,prostaglandins, etc.

This product can be used by wearers of contact lenses.

General practioctioners & Specialists

Medical Device class IIb

Presentation: 10 mol Bottle OSD

D.M.G. ITALIA S.R.L.

  • IT
  • 2020
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
Medical Devices
Nutraceuticals
OTC
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Specifications

D.M.G. ITALIA S.R.L.

  • IT
  • 2020
    On CPHI since
  • 2
    Certificates
  • 100 - 249
    Employees
Company types
Manufacturer/Innovator
Primary activities
Medical Devices
Nutraceuticals
OTC
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)

More Products from D.M.G. ITALIA S.R.L. (55)

D.M.G. ITALIA S.R.L. resources (1)